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Insomnia during acute alcohol withdrawal (AWD) as well
as persisting insomnia during postacute withdrawal is asso-
ciated with relapse. Rates of insomnia in clinical samples of
alcohol-dependent patients range from 36% to 91%, but the
prevalence of AWD-related insomnia in the general popula-
tion is unknown. The purpose of this study was to describe the
prevalence of insomnia as a symptom of acute AWD and its
correlates in a general population of alcohol-dependent indi-
viduals. Data were analyzed from the 2001 to 2002 National
Epidemiologic Survey on Alcohol and Related Conditions,
which sampled 43,093 adults. The prevalence of AWD-related
insomnia among individuals with a lifetime diagnosis of alco-
hol dependence was 31.7%, which ranked fourth among the
eight listed DSM-IV withdrawal symptoms. Among individ-
uals who met lifetime criteria for both alcohol dependence
and AWD, the prevalence of insomnia was approximately
50%. Lifetime diagnoses of major depression and drug use
disorders were significant correlates of AWD-related insom-
nia in multivariate analyses. A less than 1-year duration of
the heaviest drinking period as well as the onset of alcohol
dependence between ages 18 and 27 were negatively associ-
ated with AWD-related insomnia. AWD-related insomnia is
a common symptom among alcohol-dependent adults in the
general population and is related to lifetime co-occurring di-
agnoses, age at onset of alcohol dependence, and duration of
heaviest drinking period. Its prevalence in the general pop-
ulation provides a representative base rate against which to
compare the widely varying rates reported in clinical popula-
tions. Because of its relatively frequent prevalence and associ-
ation with relapse, assessment and treatment of AWD-related
insomnia should be routinely considered in clinical settings.
(Am J Addict 2010;19:238–244)
INTRODUCTION
The diagnostic criteria for alcohol withdrawal (AWD)
in DSM-IV include eight signs and symptoms that may
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develop within hours to days after cessation of, or reduc-
tion in, heavy and prolonged alcohol use.1 The presence
of two or more of these eight signs and symptoms are re-
quired for the diagnosis, including autonomic hyperactiv-
ity, increased hand tremor, insomnia, nausea or vomiting,
transient hallucinations or illusions, psychomotor agita-
tion, anxiety, and grand mal seizures. Little is known about
the frequency or correlates of these symptoms among indi-
viduals with alcohol dependence in the general population.
Caetano et al.2 published data on the prevalence of selected
withdrawal symptoms in three waves of the National Alco-
hol Survey during 1984, 1990, and 1992, respectively, but
insomnia was not included in those analyses.
Insomnia is an important problem among alcohol-
dependent individuals because it is common, persistent,
and associated with relapse.3 Among clinical populations,
between 36% and 91% of patients report insomnia ei-
ther while drinking or within several weeks of stopping.4–6
When rates are averaged across eight studies known to the
authors, 56% of 2,075 alcohol-dependent patients had in-
somnia, although definitions for insomnia and its temporal
relationship to AWD varied by study.4–6 Indeed, insomnia
may precede the development of heavy drinking and alco-
hol dependence,7 begin during a period of heavy drinking,
or develop and worsen during AWD. Although acute AWD
generally lasts no more than 1 week, some signs and symp-
toms such as insomnia, anxiety, and autonomic dysfunction
may persist for 3–6 months or more.1 The persistence of in-
somnia and other withdrawal symptoms deserves special
interest because of their association with relapse,3 however,
the severity of insomnia during the acute withdrawal period
may also lead to early return to drinking.8
Although fairly well studied in clinical populations,
the prevalence of AWD-related insomnia among alcohol-
dependent individuals in the general population is
unknown. Knowledge about insomnia as a withdrawal
symptom in the general population would be valuable to es-
tablish a representative base rate against which to compare
238
the widely varying rates in clinical populations. Presumably,
AWD-related insomnia would be more common among
clinical samples, because insomnia can cause distress that
leads to seeking treatment. Furthermore, not all physio-
logically dependent patients experience insomnia during
AWD, raising the question of what differentiates those who
do from those who do not.
Accordingly, the purpose of this study is to describe (1)
the prevalence of insomnia as a symptom of AWD and
(2) the correlates of AWD-related insomnia in a general
population of alcohol-dependent individuals. A description
of its prevalence and correlates in the general population
may serve to draw attention to the extent of the problem
and its clinical implications.
METHODS
Subjects, Sampling, and Interviews
This study reports findings based on data from the
2001 to 2002 National Epidemiologic Survey on Alcohol
and Related Conditions (NESARC). NESARC includes a
representative sample of 43,093 U.S. adults.9 The survey
gathered information on substance use and comorbid con-
ditions from individuals living in households and group
settings. NESARC utilized a multistage sampling design
and had an overall response rate of 81%. Data were
weighted at the individual and household levels and ad-
justed for oversampling, for nonresponse, and to be repre-
sentative of the U.S. population as assessed during the 2000
census.
U.S. Census Bureau workers administered the Alcohol
Use Disorders and Associated Disabilities Interview Sched-
ule (AUDADIS-IV). AUDADIS is a structured interview
designed for administration by trained lay interviewers.
AUDADIS-IV assesses DSM-IV substance use disorders
with good reliability.10,11 The NESARC survey, sampling




This study included survey respondents who met lifetime
DSM-IV criteria for alcohol dependence. Reliability for
past-year and prior to past-year occurrence for any alcohol
use disorder was good (κ = .76 and .73, respectively).10
Age at onset of alcohol dependence was also included in
this study.
Insomnia
Subjects with a lifetime history of alcohol use were asked
if they ever experienced each of eight different withdrawal
symptoms. The sleep-related withdrawal symptom was the
primary outcome measure in this study. For this symptom,
respondents were asked, “Did you ever have trouble falling
asleep or staying asleep when the effects of alcohol were
wearing off?” Responses were recorded for past year and
prior to the past year. In this study, lifetime alcohol-related
insomnia was measured by an endorsement of insomnia
in either timeframe (ie, past year and prior to the past
year).
Alcohol Consumption
A series of alcohol consumption measures were included
in this study. The primary measures included duration
of period of heaviest drinking (measured in years), and
the number of drinks of any alcohol usually consumed
on drinking days during their period of heaviest drinking
(number of standardized drinks). Two additional measures
regarding the timing of drinking were included, although
data for these were available only for the past 12 months.
This included frequency of drinking before 3 p.m. (past
12 months) and frequency of drinking after midnight (past
12 months). Reliability analysis revealed high intraclass
correlations for alcohol consumption measures.10 We rea-
soned that respondents with AWD-related insomnia would
be more likely to drink after midnight when sleep disrup-
tion might be at its worst.
Diagnostic Variables
Five categories of DSM-IV congruent lifetime diagnoses
were included in this study, and scored as either present
or not: non-nicotine drug use disorders (abuse or depen-
dence with heroin, hallucinogens, cocaine/crack, mari-
juana, stimulants, painkillers, tranquilizers, sedatives, and
volatile solvents); nicotine dependence; anxiety disorders
(panic disorder with or without agoraphobia, agoraphobia
without panic, social phobia, generalized anxiety); major
depressive disorder; and other mood disorders (bipolar dis-
order, dysthymia, cyclothymia).
Sociodemographics
Sociodemographic measures in this study included race
(White, African American, and other), gender, and age.
Family histories of alcohol problems were based on re-
spondents’ answers to questions assessing whether or not
their blood or natural parents (father and/or mother) had
ever “been an alcoholic or problem drinker.”
Analytic Plan
Analyses were computed using SUDAAN Version 9.0.12
This system implements a Taylor series linearization to ad-
just standard errors of estimates for complex survey sam-
pling design effects including clustered data. Chi-square
tests were used to make bivariate comparisons among the
various study variables with AWD-related insomnia. A
step-wise multivariate logistic regression was used to ex-
amine the contribution of different sets of variables in the
prediction of insomnia, including family history and so-
ciodemographics (set 1), diagnostic variables (set 2), and
alcohol consumption (set 3). Variables that were associated
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with insomnia at p < .05 were included in the multivariate
analysis.
RESULTS
Prevalence and Relative Prevalence of Withdrawal
Symptoms
As previously reported, the lifetime prevalence for alco-
hol dependence was 12.5% (SE = .4),13 and 7.5% (SE =
.2) met criteria for both alcohol dependence and AWD (ie,
they reported two or more withdrawal symptoms). At least
one withdrawal symptom was reported by 87.7% (SE =
.6) of alcohol-dependent adults. Two or more withdrawal
symptoms, required by DSM-IV to meet diagnostic criteria
of AWD, were reported by 60.1% (SE = .8) of alcohol-
dependent adults. Among respondents with lifetime al-
cohol dependence (with or without AWD), 31.7% (SE =
.9) had AWD-related insomnia. Among those with AWD,
48.8% (SE = 1.2) had AWD-related insomnia. Therefore,
about 50% of individuals who met criteria for AWD in the
general population reported AWD-related insomnia.
Table 1 provides a summary of the relative prevalence
of lifetime AWD symptoms among adults with a lifetime
history of alcohol dependence. AWD-related insomnia (ie,
trouble falling/staying asleep) was the fourth most com-
mon withdrawal symptom of the eight symptoms assessed.
It was less commonly reported than nausea (75.7%), feel-
ing unusually restless (35.5%) and sweating or heart beat-
ing fast (33.8%), and more commonly reported than feeling
anxious, shaking, hallucinations, and seizures.
Bivariate Associations with Insomnia
Chi-square tests were used to examine the associations
between insomnia and the other study variables among per-
TABLE 1. Prevalence of alcohol withdrawal symptoms among adults
with DSM-IV lifetime alcohol dependence
Lifetime history of alcohol
dependence
Total Yes % No %
Withdrawal symptom N (SE) (SE)
Nausea 4,776 75.7 (.79) 24.3 (.79)
Unusually restless 4,747 35.5 (.85) 64.5 (.85)
Sweat or heart beat fast 4,734 33.8 (.84) 66.2 (.84)
Trouble falling/staying
asleep
4,756 31.7 (.89) 68.3 (.89)
Feel anxious or nervous 4,753 29.1 (.83) 70.9 (.83)
Shake 4,771 24.8 (.86) 75.2 (.86)
See, feel, hear things 4,754 10.2 (.61) 89.8 (.61)
Fits or seizures 4,769 2.8 (.31) 97.2 (.31)
Total N refers to the total unweighted number of survey respondents
with a lifetime history of alcohol dependence. All percentages (%) and
standard errors (SE) are weighted estimates.
sons with a lifetime history of alcohol dependence. In these
analyses, eight of 14 variables were significantly associated
with insomnia as a withdrawal symptom (Table 2): fam-
ily history of alcohol dependence, female gender, ages 35–
54 years, lifetime diagnosis of other drug use disorder (ex-
cluding nicotine); lifetime diagnoses of major depression
and anxiety disorders; a later age of onset of alcohol de-
pendence; and a longer duration of the heaviest drinking
period. The usual number of drinks per day during the heav-
iest drinking period was not significantly associated with
AWD-related insomnia. Nicotine dependence and time-of-
day effects for drinking were also not significantly related.
Multivariate Associations with Insomnia
A logistic regression model was developed in three steps,
using only significant variables from the bivariate analyses
(Table 3). In the first step, family history of alcohol prob-
lems and sociodemographics (ie, age and sex) were entered
into the model. Like the bivariate associations, having a
family history of substance use problems, being 35–54 years
of age, and being female were significant factors associated
with insomnia as a withdrawal symptom. In the second
step, co-occurring psychiatric diagnoses were added to the
model. Although a lifetime major depressive disorder and
lifetime drug use disorder were associated with insomnia in
this second step, lifetime anxiety disorder and sex were no
longer significant.
In the third step of the model, alcohol consumption vari-
ables were included, after which none of the family history
and sociodemographic variables were significant. Respon-
dents with lifetime major depressive episode and lifetime
drug use disorder were 38% and 26% more likely to report
insomnia (respectively) compared to respondents without
these conditions. Age of alcohol dependence onset was also
significantly associated with insomnia. Specifically, respon-
dents with an age of alcohol dependence onset from 18 to
20 and 21 to 27 years of age were approximately 30% and
26% less likely to report insomnia compared to those with
an onset of 28 years or older (respectively). Those with the
shortest duration of heaviest drinking (ie, ≤1 year) were
25% less likely to report insomnia compared to those with
the longest duration (ie, 7+ years).
DISCUSSION
The major finding in this study was that nearly one-
third of individuals in the general population who met life-
time criteria for alcohol dependence reported insomnia as
a withdrawal symptom. This contrasts with an estimated
rate of 58% in clinical populations. However, about 50% of
individuals who met criteria for AWD in the general pop-
ulation reported insomnia as one of its symptoms. Among
the eight criterion withdrawal symptoms listed in DSM-
IV, insomnia ranked fourth behind nausea, restlessness,
and autonomic symptoms (sweating or heart beating fast).
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TABLE 2. Bivariate associations between trouble falling/staying asleep and demographic, psychosocial, and clinical measures among adults with
a lifetime history of alcohol dependence
Trouble falling/staying asleep
Variable Categories Yes (N = 1,499) % (SE) χ2 (df)
Sex Male 29.7 (1.2) 10.4 (1)∗∗
Female 35.8 (1.5)




Race White 32.1 (1.0) 1.8 (2)
African American 27.4 (2.4)
Other 31.7 (2.3)
Family history of AUD Yes 35.8 (1.3) 14.2 (1)∗∗∗
No 29.4 (1.2)
Lifetime history of major depressive disorder Yes 38.4 (1.5) 32.6 (1)∗∗∗
No 27.9 (1.1)
Lifetime history of other mood disorder Yes 29.8 (3.3) .4 (1)
No 31.8 (.9)
Lifetime history of anxiety disorder Yes 37.9 (1.9) 14.8 (1)∗∗∗
No 29.7 (.9)
Lifetime drug use disorder (excluding nicotine) Yes 36.1 (1.6) 14.0 (1)∗∗∗
No 28.8 (1.0)
Lifetime history of nicotine dependence Yes 33.0 (1.3) 2.3 (1)
No 30.4 (1.1)
No. drinks of any alcohol usually consumed during 1–3 32.7 (1.9) 1.8 (3)
period of heaviest drinking 4–5 33.3 (1.8)
6–10 30.4 (1.4)
11+ 32.0 (2.1)








How often drank before 3 p.m. in last 12 months 3–7 times weekly 35.7 (3.5) 5.79 (3)
2–3 times monthly 31.0 (3.3)
Monthly or less† 31.8 (1.5)
None 28.5 (1.2)
How often drank after midnight in last 12 months 3–7 times weekly 35.1 (3.4) 3.1 (3)
2–3 times monthly 32.6 (3.1)
Monthly or less† 30.2 (1.3)
None 29.4 (1.6)
Total N refers to the total unweighted number of survey respondents with a lifetime history of alcohol dependence. ∗p < .05, ∗∗p < .01, ∗∗∗p < .001.
†Monthly or less (but at least one time). All percentages (%) and standard errors (SE) represent weighted row estimates.
Similarly, insomnia ranked third among 12 different with-
drawal symptoms when calculated for a combined clinical
sample of 1,193 patients.2
A family history of alcohol use disorders, female gen-
der, middle age (35–54 years), non-nicotine lifetime drug
use disorders, lifetime major depression and anxiety dis-
orders, later age of onset (after 27 years old) for alcohol
dependence, and 7 or more years of heavy drinking were
associated with insomnia in bivariate analyses. Drinks per
drinking day during the heaviest period of drinking and
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TABLE 3. Multivariate association between trouble falling/staying asleep and demographic, psychosocial, and clinical variables based on logistic
regression analysis
Step 1 Step 2 Step 3
Variables AOR (95% CI) AOR (95% CI) AOR (95% CI)
Age
18–25 Ref Ref Ref
26–34 1.09 (.84–1.42) 1.08 (.83–1.41) 1.0 (.76–1.31)
35–54 1.62 (1.29–2.02) 1.57 (1.25–1.97) 1.28 (.99–1.66)
55+ 1.01 (.75–1.34) 1.06 (.79 – 1.43) .81 (.58–1.12)
Sex
Male Ref Ref Ref
Female 1.27 (1.06–1.52) 1.17 (.97–1.42) 1.16 (.96–1.40)
Family history of alcohol problems
Yes 1.29 (1.10–1.50) 1.19 (1.01–1.40) 1.16 (.99–1.37)
No Ref Ref Ref
Lifetime major depressive episode
Yes – 1.37 (1.14–1.65) 1.38 (1.15–1.66)
No Ref Ref
Lifetime anxiety disorder
Yes – 1.14 (.93 – 1.40) .88 (.71–1.08)
No Ref Ref
Lifetime drug use disorder (excluding nicotine)
Yes – 1.26 (1.06–1.51) 1.26 (1.05–1.52)
No Ref Ref
Age of onset categorized




Duration (in years) of period of heaviest drinking




Overall model fit 54.37 (p < .001) 42.32 (p < .001) 24.85 (p < .001)
Adjusted Wald F
AOR = adjusted odds ratio; values in bold are statistically significant based on a 95% confidence interval that does not bound 1.0. CI = confidence
interval; Ref = reference group.
time of day of drinking in the past 12 months were not
associated. In the multivariate analysis, which included all
significant variables from the bivariate analyses, four vari-
ables remained as significant predictors of AWD-related
insomnia. Lifetime diagnoses of major depressive episodes
and drug use disorders (excluding nicotine) were associated
with AWD-related insomnia, whereas onset of alcohol de-
pendence between ages 18 and 27 as well as a 1-year or less
period of heaviest drinking were protective factors.
From a diagnostic perspective, insomnia was not in-
cluded as a symptom criterion of AWD when DSM-III
was published in 1980,14 but did appear in the 1987 pub-
lication of DSM-III-R15 and remains so in DSM-IV-TR.1
Similarly, despite its relatively high prevalence, insomnia is
not included in the commonly and currently used AWD rat-
ing scale, the 10-item revised Clinical Institute Withdrawal
Assessment scale for Alcohol (CIWA-Ar),16 nor its 15-item
parent scale17 and derivatives.18,19 Another scale by De-
Petrillo and McDonough20 also omits sleep disturbances.
AWD scales that do include sleep disturbances, such as the
Selected Severity Assessment,21 its modified version—the
Abstinence Symptom Evaluation Scale22—and the Rating
Scale for Assessment of Alcohol Withdrawal Psychopathol-
ogy,6 are infrequently used in clinical practice.
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AWD rating scales are generally designed to assess the
severity of symptoms across multiple time points within
a single day to determine when detoxification medications
should be administered to prevent medical complications
such as delirium tremens or seizures. In this respect, an
insomnia item would not change within a single day and,
therefore, not add value to the rating scale. Nevertheless, pa-
tients that do not sleep well during and recently after acute
withdrawal may be at higher risk for relapse.3,8 Therefore,
the presence of insomnia during withdrawal is very impor-
tant for treatment purposes, even though it is not useful for
guiding doses of medications for detoxification during the
daytime.
Benzodiazepines, which are the evidence-based medica-
tions of choice for pharmacological detoxification during
AWD,23,24 may also be administered at night for AWD-
related insomnia according to the same protocol used
for daytime symptoms. This common practice of treating
AWD-related insomnia, however, may need to be recon-
sidered given mounting evidence that benzodiazepines are
less effective than anticonvulsants such as gabapentin and
carbamazepine for treating AWD-related insomnia8,25 and
preventing relapse.8
Limitations of this study include the use of a single in-
somnia item related to AWD. Insomnia as either an inde-
pendent symptom or diagnosis cannot be determined from
the NESARC data set. Another limitation is the potential
bias of retrospective recall, which is inherent to all surveys
that ask respondents to remember and report diagnostic
symptoms across a lifetime of drinking. The cross-sectional
design of the study and the use of lifetime diagnoses do
not permit the term, predictor, to be used except in a sta-
tistical sense when describing correlates of AWD-related
insomnia. Nevertheless, the study is strengthened by its use
of a representative national sample of adults with alcohol
dependence, which provides a base rate against which to
compare the widely variable rates of insomnia reported in
clinical samples.
In conclusion, the relatively high prevalence of AWD-
related insomnia in both the general and clinical popula-
tions, and its association with relapse in clinical samples,
suggests that reliance on rating scales for AWD that do
not include or characterize insomnia may be insufficient
for both assessment and treatment purposes. The use of
rating scales for, and targeted treatment of, AWD-related
insomnia deserves consideration as a treatment guideline
for alcohol-dependent patients.
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